pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
PUBLIC COMPANY
save

Emory University

updated 3mo ago

Emory University is a private research university in Atlanta, Georgia, United States. It was founded in 1836 as Emory College by the Methodist Episcopal Church and named in honor of Methodist bishop John Emory. Its main campus is in Druid Hills, four miles from downtown Atlanta.

community read0 votes

🐶 often sniffed alongside

top 8
  • tagType 2 Diabetes2 co-mentions · 2 sources
  • tagImmunology2 co-mentions · 2 sources
  • tagHepatology2 co-mentions · 2 sources
  • tagSickle Cell Disease2 co-mentions · 2 sources
  • drugAlzheimer's Disease2 co-mentions · 2 sources
  • tagAlzheimer's Disease2 co-mentions · 2 sources
  • tagCardiology1 co-mentions · 1 sources
  • tagOncology1 co-mentions · 1 sources
pipeline
0
marketed
0
phase 3
0
catalysts ytd
34
approvals ytd
0
recalls ytd
0

Pipeline(0)

no pipeline products on record

📅 Upcoming

no upcoming catalysts on record

🕒 Recent(90d)

nothing in the last 90 days
view all catalysts →

Active trials

  • phase2Baricitinib Curative Repression of HIV-1not yet recruitingn=35
  • phase1VX15/2503 in Combination With Ipilimumab or Nivolumab in Patients With Head and Neck Canceractive not recruitingn=35
  • phase1VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanomaactive not recruitingn=41
  • phase2Lenvatinib for the Treatment of Recurrent Hepatocellular Carcinoma After Liver Transplantterminatedn=3
  • phase1Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastasesterminatedn=1
  • phase2Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinomaactive not recruitingn=18
  • phase2Iberdomide Alone or in Combination With Dexamethasone for the Treatment of Intermediate- or High-Risk Smoldering Multiple Myelomarecruitingn=68
  • N/ATailored Electronic Intervention to Improve Therapy in a Diverse Cohort of Patients With Heart Failurerecruitingn=4,000
more trials →
🐶 Hiring Signal
No open roles indexed yet — view Emory University jobs →

News

  • Opinion: How should states reach out to Medicaid enrollees affected by changes? Our research gives a hint
    Experts ask: How can we better reach out to people facing Medicaid renewal deadlines and support them through the paperwork requirements?
    stat · 11d ago
  • Opinion: CDC leadership continues to try to manufacture a scientific debate on vaccines where none exists
    CDC leadership continues to try manufacture a scientific debate on vaccines where none exists, writes Ben Lopman.
    stat · 1mo ago
  • Opinion: The virtual end of the doctor’s office waiting room
    It’s time to rethink and redesign how patients enter the health care system altogether, writes emergency physician Iyesatta Massaquoi Emeli.
    stat · 2mo ago
  • Hantavirus risk remains low, CDC says, citing its ‘playbook’ response
    Despite rising concern about the hantavirus outbreak on a cruise ship, two CDC doctors say the risk to the public remains low.
    stat · 3mo ago
  • GU Cancer Experts Highlight Top Abstracts to Watch During ASCO 2026
    We spoke with leading voices in GU oncology to see which presentations they are most looking forward to during the 2026 ASCO Annual Meeting.
    onclive · 3mo ago
  • The aging scientific workforce collides with rising fabricating citations in medical journals
    The latest in the hantavirus cruise ship saga, why these former officials left the FDA, and more health news from Morning Rounds
    stat · 3mo ago
  • Opinion: We need more men in nursing
    Men make up just 12% of nurses nationally. That needs to change.
    stat · 3mo ago
  • ASCO 2026 TNBC Deep Dive: Breast Cancer Experts Preview Practice-Informing Studies
    Experts spotlight the triple-negative breast cancer abstracts they’re most excited to see at the 2026 ASCO Annual Meeting.
    onclive · 3mo ago
  • ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Go
    Breast cancer experts spotlight the abstracts they’re most excited to see at the 2026 ASCO Annual Meeting.
    onclive · 3mo ago
  • Securing NIH awards is getting more competitive — and confusing
    The likelihood of snagging NIH grants has plunged to historic lows, forcing academic researchers to resort to a variety of tactics to try to obtain funding
    stat · 3mo ago
view all news mentions →
identifiers
source
globaldata
mentioned in
10news items
entity-linker matched

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?